The global Electrocardiogram market size is expected to reach USD 224.65 Billion in 2030 and register a CAGR of 8.0% over the forecast period, according to the latest report by Reports and Data. Rising prevalence of CAD and increasing technological advancements in cardiovascular diagnostics are some key factors expected to drive market revenue growth over the forecast period. In addition, increasing number of obese population due to various factors such as excessive drinking, smoking, sedentary lifestyle, unhealthy eating habits, and no time for physical activities is contributing to rising cases of heart-related conditions globally, which is expected to support revenue growth of the global market.

Recent technological advancements in diagnostic imaging techniques is expected to drive market revenue growth of a significant extent. Availability of multiple imaging modalities is enabling healthcare professionals to accurately evaluate patients suspected of having coronary ischemia. Various imaging techniques such as stress echocardiography, stress electrocardiography, myocardial perfusion imaging, and magnetic resonance imaging among others is significantly improving treatment process by providing both anatomical and functional information of coronary stenosis. Computed Tomography (CT) angiography with perfusion, whole-heart magnetic resonance angiography, CT fractional flow reserve are evolving diagnostic pathway which has also been increasingly incorporated into routine clinical practice for diagnosing patients with CAD and this is expected to further drive market revenue growth over the forecast period. 

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4132

Some Key Factors Contributing to the Global Pharma Healthcare Market Growth

Unprecedented revenue growth of the global pharma healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in RD activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some Key Highlights From the Report:

• In March 2021, Koninklijke Philips N.V. announced the launch of AI-enabled Precise Suite solution for the company’s incisive CT platform. The new technology provides smart workflows by utilizing AI-enabled image reconstruction technology, facilitating automated patient positioning, capturing motion-free cardiac image capture and enabling healthcare professionals to gain real-time interventional guidance, improve operational efficiency and provide quality care.
• Electrocardiogram (ECG) segment is expected to account for largest revenue share during the forecast period attributable to increasing use of ECG diagnostic procedures in the diagnosis of cardiac conditions such as arrhythmia, congenital heart defects, coronary occlusion among others.
• Hospitals segment is expected to lead in terms of revenue share over the forecast period owing to growing number of trans-catheter structural heart surgery and coronary artery bypass grafting procedures performed in hospitals to diagnose and treat coronary artery disease.
• Non-invasive segment is expected to register robust revenue growth over the forecast period owing to increasing adoption of technologically advanced non-invasive diagnostic imaging modalities for providing real-time visualization of arterial wall and high-resolution image for accurate diagnosis of coronary artery disease.
• North America is expected to account for largest revenue share over the forecast period attributable to rising number of elderly population, increasing demand for advanced diagnostic imaging techniques and growing investment in RD activities for significantly improving identification and screening of heart diseases and contribute to improved diagnosis and facilitate targeted treatment.

Top Players in the Global Electrocardiogram Market:

Schiller AG, Siemens Healthineers AG, GE Healthcare Inc., F.Hoffman La-Roche Ltd., Midmark Corporation, Koninklijke Philips N.V., Hitachi Ltd., AstraZeneca PLC, Welch Allyn Inc., and Canon Medical Systems Corporation.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma healthcare industry revenue growth over the recent past.  

To know more about the report @ https://www.reportsanddata.com/report-detail/heart-attack-diagnostics-market

Electrocardiogram Market Segmentation:

Diagnostics Procedure Outlook (Revenue, USD Billion; 2019-2030)

• Invasive Procedure
• Non-Invasive Procedure

Test Type Outlook (Revenue, USD Billion; 2019-2030)

• Electrocardiogram (ECG or EKG)
• Echocardiogram
• Stress Test
• Cardiac Catheterization
• Cardiac Computerized Tomography (CT) Scan
• Cardiac Magnetic Resonance Imaging(MRI)
• Blood Test
• Others

End-Use Industry Outlook (Revenue, USD Billion; 2019-2030)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostics Centers
• Others

Global Electrocardiogram Market Report: Regional Segmentation

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4132

Read More Reports:

In-Vitro Diagnostics Market: https://www.reportsanddata.com/report-detail/global-in-vitro-diagnosticsivd-market

Dental Burs Market: https://www.reportsanddata.com/report-detail/dental-burs-market

Duodenoscope Market: https://www.reportsanddata.com/report-detail/duodenoscope-market

Cinitapride Market: https://www.reportsanddata.com/report-detail/cinitapride-market

Dental Curing Lights Market: https://www.reportsanddata.com/report-detail/dental-curing-lights-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.